Stocks & Investing
Wed, September 11, 2024
[ Wed, Sep 11th 2024
] - WOPRAI
Thu, July 25, 2024
[ Thu, Jul 25th 2024
] - WOPRAI
Tue, April 30, 2024
[ Tue, Apr 30th 2024
] - WOPRAI
Fri, March 1, 2024
[ Fri, Mar 01st 2024
] - WOPRAI
Fri, February 16, 2024
[ Fri, Feb 16th 2024
] - WOPRAI
Thu, January 18, 2024
[ Thu, Jan 18th 2024
] - WOPRAI
Tue, November 14, 2023
[ Tue, Nov 14th 2023
] - WOPRAI
Wed, November 8, 2023
[ Wed, Nov 08th 2023
] - WOPRAI
Wed, September 6, 2023
[ Wed, Sep 06th 2023
] - WOPRAI
Mon, August 21, 2023
[ Mon, Aug 21st 2023
] - WOPRAI
Mon, August 7, 2023
[ Mon, Aug 07th 2023
] - WOPRAI
Fri, July 21, 2023
[ Fri, Jul 21st 2023
] - WOPRAI
[ Fri, Jul 21st 2023
] - WOPRAI
Fri, May 26, 2023
[ Fri, May 26th 2023
] - WOPRAI
Tue, May 9, 2023
[ Tue, May 09th 2023
] - WOPRAI
Wed, March 29, 2023
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
Tue, September 27, 2022
[ Tue, Sep 27th 2022
] - WOPRAI
Fri, July 29, 2022
Wed, June 29, 2022
[ Wed, Jun 29th 2022
] - WOPRAI
Fri, November 12, 2021
[ Fri, Nov 12th 2021
] - WOPRAI
Tue, November 2, 2021
[ Tue, Nov 02nd 2021
] - WOPRAI
Wed, April 28, 2021
[ Wed, Apr 28th 2021
] - WOPRAI
Gregory Fraser Downgraded (ANIP) to Hold and Decreased Target to $60 on, Sep 11th, 2024
Gregory Fraser of Truist Securities, Downgraded "ANI Pharmaceuticals, Inc." (ANIP) to Hold and Decreased Target from $80 to $60 on, Sep 11th, 2024.
Gregory has made no other calls on ANIP in the last 4 months.
There is 1 other peer that has a rating on ANIP. Out of the 1 peers that are also analyzing ANIP, 0 agree with Gregory's Rating of Hold.
This is the rating of the analyst that currently disagrees with Gregory
- Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $94 on, Wednesday, August 7th, 2024
